The purposes of this study were to determine if coronary dilation secondary to an increase in myocardial oxygen consumption (MVO 2 ) affects the microcirculation in a homogeneous or heterogeneous manner and to determine if comparable degrees of coronary dilation produced by increasing MVO 2 or exogenous (intravenous adenosine) or endogenous (intravenous dipyridamole) adenosine have similar effects In the coronary microcirculation. The epimyocardial coronary microcirculation was observed through an intravital microscope by stroboscopic epi-illumination in anesthetized open-chest dogs. Aortic pressure and heart rate were controlled by an aortic snare and atrioventricular sequential pacing, respectively, during experimental procedures. In group 1 (n = 15), coronary arterial microvessel diameters were measured under control condition and during rapid pacing at 300 beats/min, which doubled MVO 2 . Increases in MVO] caused heterogeneous vasodilation in coronary arterial microvessels (40-380 jim). There was an inverse relation between control diameter and percent increase in diameter. In group 2 (n=15) or group 3 (/t=10), adenosine or dipyridamole was infused intravenously to increase myocardial perfusion to the same level as that obtained with rapid pacing. Adenosine and dipyridamole did not change MVO 2 . Adenosine and dipyridamole also caused heterogeneous vasodilation, but the effects of adenosine and dipyridamole were restricted to arterial microvessels smaller than 150 /tm. From these results, we conclude that increases in MVO 2 produce widespread but heterogeneous vasodilation, that is, greater dilation in smaller arterial microvessels. Comparable increases in coronary flow produced by increasing MVO 2 or endogenous and exogenous adenosine do not produce identical changes in the distribution of coronary microvascular resistance. (Circulation Research 1989;65:1296-1305 L eft ventricular coronary blood flow and myocardial oxygen consumption (MV0 2 ) are closely coupled. 1 -5 Metabolic vasocontrol has been thought to occur primarily at the small arteriole level because, in most organs, the most resistive segment to blood flow exists in arterial microvessels smaller than 100 /xm. 6 -8 However, in the coronary circulation, previous technological limitations have prevented investigators from studying in greater detail the effects of a metabolic stimulus on the distribution of microvascular resistance throughout the entire vascular tree.
The purposes of this study were to determine if coronary dilation secondary to an increase in myocardial oxygen consumption (MVO 2 ) affects the microcirculation in a homogeneous or heterogeneous manner and to determine if comparable degrees of coronary dilation produced by increasing MVO 2 or exogenous (intravenous adenosine) or endogenous (intravenous dipyridamole) adenosine have similar effects In the coronary microcirculation. The epimyocardial coronary microcirculation was observed through an intravital microscope by stroboscopic epi-illumination in anesthetized open-chest dogs. Aortic pressure and heart rate were controlled by an aortic snare and atrioventricular sequential pacing, respectively, during experimental procedures. In group 1 (n = 15), coronary arterial microvessel diameters were measured under control condition and during rapid pacing at 300 beats/min, which doubled MVO 2 . Increases in MVO] caused heterogeneous vasodilation in coronary arterial microvessels (40-380 jim). There was an inverse relation between control diameter and percent increase in diameter. In group 2 (n=15) or group 3 (/t=10), adenosine or dipyridamole was infused intravenously to increase myocardial perfusion to the same level as that obtained with rapid pacing. Adenosine and dipyridamole did not change MVO 2 . Adenosine and dipyridamole also caused heterogeneous vasodilation, but the effects of adenosine and dipyridamole were restricted to arterial microvessels smaller than 150 /tm. From these results, we conclude that increases in MVO 2 produce widespread but heterogeneous vasodilation, that is, greater dilation in smaller arterial microvessels. Comparable increases in coronary flow produced by increasing MVO 2 or endogenous and exogenous adenosine do not produce identical changes in the distribution of coronary microvascular resistance. (Circulation Research 1989; 65:1296 -1305 L eft ventricular coronary blood flow and myocardial oxygen consumption (MV0 2 ) are closely coupled. 1 -5 Metabolic vasocontrol has been thought to occur primarily at the small arteriole level because, in most organs, the most resistive segment to blood flow exists in arterial microvessels smaller than 100 /xm. 6 -8 However, in the coronary circulation, previous technological limitations have prevented investigators from studying in greater detail the effects of a metabolic stimulus on the distribution of microvascular resistance throughout the entire vascular tree.
Recent measurements of microvascular pressure in various-sized coronary microvessels 9 -11 indicate that a broad range of sizes of coronary microvessels contributes to total coronary vascular resistance. Under control conditions, about 50% of coronary vascular resistance resides in arteriolar microvessels greater than 100 /u.m in diameter. 11 Because coronary vascular resistance is distributed over a broad range of sizes of microvessels, it is unlikely that the response to a potent dilator stimulus would only involve a small range of sizes of coronary microvessels. Thus, one of the goals of this investigation was to determine the effects of a metabolic dilator stimulus, rapid pacing, on the distribution of coronary vascular resistance. We postulated that a broad range of sizes of coronary microvessels would contribute to the decrease in coronary vascular resistance associated with an increase in MVO 2 .
Previous in vitro studies have suggested that large and small coronary vessels do not respond equally to adenosine. 12 -14 Furthermore, a drug that increases endogenous levels of adenosine (dipyridamole) did not have a uniform dilator effect on various-sized coronary microvessels. 15 Thus, it was likely that adenosine would not have a uniform effect on the distribution of coronary microvascular resistance. Therefore, a second goal of these investigations was to determine the effects of adenosine on the distribution of microvascular resistance. We used a dose of adenosine or dipyridamole that decreased coronary vascular resistance to a similar extent as that produced by our metabolic stimulus, rapid pacing.
Materials and Methods

General Preparation
Small mongrel dogs (/i=40) of either sex weighing 3-10 kg were sedated with ketamine (20 mg/kg i.m.) and isopromazine (0.2 mg/kg i.m.) and anesthetized with o-chloralose (a-chloralose 50 mg/kg+sodium borate 50 mg/kg i.v.). If necessary, additional doses were given to maintain anesthesia. Body temperature was maintained at 37°-38° C by means of a homeothermic blanket system. The femoral artery was catheterized for aortic pressure measurement and reference blood collection for measurement of myocardial perfusion. The tip of this catheter was positioned in the aortic arch. Two catheters were inserted into the femoral vein to administer fluid and drugs independently. A solid-state transducer (model 5F, Millar, Houston, Texas) was advanced into the left ventricle via the right carotid artery for measurement of left ventricular pressure and dP/dt. A cuffed tracheal tube was introduced into the trachea. A positive end-expiratory pressure of 3-5 cm H 2 O was used to prevent atelectasis. Highfrequency jet ventilation was used to reduce cardiac movement caused by pulmonary inflation. For this procedure, an 18-gauge cannula was also inserted into the trachea and advanced to 5-6 cm above the carina and then connected to the jet ventilator. The jet ventilator, which consists of a solenoid valve and a pressure regulator, was connected to compressed air. A solenoid valve, triggered from a pulsed stimulator (120-150 pulse/min), was opened for 30-40 msec during a respiratory cycle, and pressure in the tracheal cannula was regulated to 5-15 psi. Arterial blood gases and pH were maintained within the physiological range by changing the frequency and/or the duration that the solenoid valve was opened, the positive end-expiratory pressure, and/or the regulated pressure.
After these procedures, a thoracotomy was performed in the left fifth intercostal space, and the pericardium was opened. The epicardial surface was kept moist by dripping mineral oil on it. 11 A plastic wrapping was used to separate the lung from the anterior aspect of the heart and to prevent the lung from drying. The left atrium was catheterized via the left atrial appendage. A 4F catheter was introduced into the coronary sinus via the left external jugular vein. The tip of this catheter waŝ dvaaced 2.0-2.5 cm from the orifice to avoid contamination of right atrial blood. A snare was placed around the descending thoracic aorta for control of arterial pressure. Two pairs of pacing electrodes were attached to the left atrium and to the left ventricular apex. The sinus node was suppressed by injecting formaldehyde (7% buffered formaldehyde, 0.3-0.6 ml) into the region of the sinus node. Heart rate was controlled by atrioventricular sequential pacing (atrioventricular interval, 50 msec).
Partial Left Ventricular Restraint
The anterior left ventricular free wall was partially restrained to limit excessive movement by inserting four to five 22-gauge needles (4-5 mm apart) from the anterior left ventricular free wall to the lateral left ventricular free wall. These needles were fixed to the animal table via a needle holder. All measurements of microvascular diameter were made in a segment of the left ventricle at least 10 mm distant from a pin entry or exit site. Although this procedure partially restrained the contraction of the left ventricle, the epicardium of this region moved about 0.5-1.5 mm vertically and horizontally during the cardiac cycle. Thirty minutes were allowed for stabilization of the preparation after the insertion of the pins. 11
Microvascular Preparation
Measurements of microvascular diameter in the beating heart were accomplished with an intravital microscope (Ploemopak, E. Leitz, Rockleigh, New Jersey) equipped with a silicon-intensified tube video camera (General Electric). The epimyocardium was epi-illuminated using a stroboscopic light source (150W xenon arc, Chadwick-Helmuth, Elmonte, California). The strobe was triggered by the left ventricular dP/dt signal and flashed once per cardiac cycle at the same point of end diastole during successive cardiac cycles. By this illumination technique, which was developed originally by Nellis et al, 9 the epicardial microvasculature appeared to be motionless when viewed through the microscope. Polarizing filters were used to reduce the glare from the epicardial surface. The microscope objectives used for this study were a Leitz A6 (x6, n.a. 0.18) and Leitz L10 (xlO, n.a. 0.22). A Leitz L10 was used for the observation of vessels smaller than 150 ixm in diameter. Resolution of our measurement system was 5 and 8 /urn for the XlO and x6 objectives, respectively. 16 The images, obtained by our video camera, were digitized with a video digitizer (Imaging Technology, Woburn, Massachusetts), displayed on a highresolution video monitor (Panasonic), and tempo-rarily stored in the computer on a hard disc or transferred to magnetic tape for long-term storage.
Diameters of microvessels were measured using digitized images that were displayed on the high resolution monitor. Cursors were aligned with the vessel edges by means of a digitizing tablet (Summagraphics, Fairfield, Connecticut), and a computer program was used to calculate the vessel diameter in microns. Each vessel was measured three to six times by use of different images of the same vessel obtained consecutively within 15 seconds.
To distinguish arterial microvessels from venous microvessels, fluorescein isothiocyanate dextran (MW, 149,700) was injected as a 20-mg bolus into the left atrium. The fluorescein molecule was activated and visualized by means of fluorescent techniques with filters (Leitz H 2 filter) and a Ploemopak system. With this technique, arterial microvessels appeared a few seconds before venous microvessels.
In the present study, we measured arterial microvessel diameters at end diastole. If there are significant cyclic changes in arterial microvessel diameters in each cardiac cycle, the magnitude of the differences between measurements made at different points in the cardiac cycle would be important. Therefore, in the preliminary study of dogs instrumented similarly, measurements of the same arterial microvessel diameters made at midsystole, early diastole, and end diastole were compared over a wide range of vessel sizes.
Experimental Protocol
To study the effects of a metabolic stimulus on coronary arterial microvessels, microvascular diameter, myocardial perfusion, MV0 2 , and hemodynamics were measured under control conditions and during rapid pacing at 300 beats/min in 15 dogs (group 1). All measurements were performed 5-15 minutes after rapid pacing was begun and hemodynamics were stable. In group 2 (rc = 15) or group 3 (n = 10), to determine the effect of adenosine or dipyridamole infusion on coronary arterial microvessels, microvascular diameter, myocardial perfusion, MVO 2 , and hemodynamics were measured under control conditions and during continuous infusion of intravenous adenosine or after intravenous bolus injection of dipyridamole. To match the effect of rapid pacing and adenosine or dipyridamole on coronary flow, it was necessary to examine several doses of adenosine (0.1-0.4 mg/kg • min) or dipyridamole (0.2-0.3 mg/kg) injection in each dog. Measurements were performed 5-15 minutes after the onset of adenosine infusion or dipyridamole injection when hemodynamics were stable. In group 3, dipyridamole was added cumulatively, and all measurements were completed within 1 hour. In groups 1 and 2, microvascular diameters were measured again 45-60 minutes after the cessation of rapid pacing ^qr adenesine irtfusTon. After these procedures were completed, a large dose of adenosine (1.1 mg/kg • min, n=6) or dipyridamole (1.0 mg/kg, n=5) was infused to assess coronary reserve in the unrestrained and restrained areas of the left ventricle and to assess the maximal vasodilator effect of each agent. Arterial pressure was kept at the same level as control in these experimental conditions by adjusting an aortic snare.
Measurement of Saturation O 2 , Hemoglobin, and Myocardial Perfusion
After diameter measurements were obtained, arterial and coronary sinus blood samples were anaerobically collected into heparinized 1-ml syringes, and O 2 saturation and hemoglobin concentration were measured immediately with a co-oximeter (model 182, Instrumentation Laboratory, Lexington, Massachusetts).
Myocardial perfusion was measured with nuclidelabeled microspheres (15-^m diameter labeled with "Sc, ^S r, 113 Sn, 85 Nb, 141 Ce, 103 Ru, 57 Co, and 109 Cd). Microspheres (l.OxlO M .SxlO 6 ) were agitated and injected into the left atrium, and the cannula was immediately flushed with 2 ml saline. Starting 30 seconds before injection and continuing until 1.5 minutes after the injection, arterial blood was collected with a constant withdrawal pump from the femoral arterial line at a rate of 1.91 ml/min. Blood reference samples were placed in counting vials to count nuclide activity. After completion of this study, the heart was excised and tissue samples were obtained from the anterior left ventricular free wall (restrained area), posterolateral left ventricular free wall, and the septum. These samples were divided into three layers: epicardium, midwall, and endocardium. Myocardial blood flow per 100 g (MBF) was calculated according to the following expression:
MBF=
CmxWrxlQQ (gr where Cm is nuclide activity per gram weight of tissue, Wr is withdrawal rate of the pump (ml/min), and Cr is total nuclide activity in the blood reference sample. Nuclide activity was determined with a germanium detector. 17 Coronary vascular resistance was calculated by dividing the mean aortic pressure by myocardial perfusion per 100 g. MVO 2 was calculated with arterial and coronary sinus O 2 saturation, hemoglobin, and myocardial perfusion.
Calculation of Hindrance
Hindrance changes of arterial microvessels were calculated from alterations in microvessel diameter 18 according to the following expression:
where r c is the control diameter and r x is the diameter during rapid pacing or adenosine infusion. Hindrance 
Criteria for Data Selection
Experiments were only included in the final data analysis if the following criteria were met: 1) mean aortic pressure of 70 mm Hg or more, 2) changes in mean aortic pressure between control conditions and metabolic stimulation and between adenosine or dipyridamole infusion of 10 mm Hg or less, and 3) arterial oxygen tension of 70 mm Hg or more.
In addition, changes in diameter during rapid pacing or adenosine infusion had to return to a value within ±5% of the control after the cessation or rapid pacing or adenosine infusion. Furthermore, in group 2 and group 3 studies, changes in MV0 2 during adenosine infusion must have been not more than 40% of the control value.
Data Analysis
All hemodynamic variables (systolic, diastolic, mean arterial pressure, and heart rate) were recorded on a Gould recorder (Cleveland, Ohio). The numbers of vessels examined in each dog varied between one and five (mean, 2.5) in the group 1 dogs, between one and four (mean, 2) in the group 2 dogs, and between one and four (mean, 3.1) in the group 3 dogs. For multiple comparison of data between three groups, analysis of variance was used to assess the statistical significance of the observed differences. When significant values were obtained, unpaired t test (corrected for multiple comparisons with the Bonferroni inequality adjustment) was used to determine which measurements differed significantly from one another. For comparison of paired samples in each group, Student's t test for paired samples was used when appropriate. All data are expressed as a mean±SEM, and/?<0.05 was used as the probability level for statistical significance.
Results
Blood Gases, Hemodynamics, Myocardial Perfusion, and MVO 2
Under control conditions, blood gases, left ventricular myocardial perfusion, and MV0 2 were comparable in the groups subjected to rapid pacing and adenosine and dipyridamole infusion ( Table 1 , Figure 1) . Hemoglobin was slightly lower in group 3 when compared with other groups, but it was in a physiological range (Table 1 ). Furthermore, our protocol resulted in a comparable increase in myocardial perfusion in the three experimental groups (Table 1, Figure 1 ). Rapid pacing caused a significant increase in MV0 2 (Table 1, Figure 1 ).
Effect of Restraint on Regional Myocardial Perfusion
Under control conditions and during the experimental procedure (rapid pacing or adenosine or dipyridamole infusion), there were no significant differences in transmural myocardial perfusion and coronary vascular resistance between the restrained and nonrestrained areas. However, the subendocardial/ subepicardial ratio was lower in the restrained area 
Measurements of Coronary Arterial Diameter at Various Points in the Cardiac Cycle
Measurements of the same arterial microvessel diameters made at midsystole, early diastole, and end diastole showed almost no change (Figure 3 ). When diameters measured at end diastole were compared with those measured at midsystole, diameter changes were -l.l±0.9 (n=13) and 0.1±0.7% («=13) at heart rates less than 150 beats/min or 270-300 beats/min, respectively. There were no significant differences in arterial diameters measured at midsystole and end diastole.
Diameter Changes in Coronary Arterial Microvessels: Effects of Increased MVO 2 Consumption (Group 1)
During rapid pacing and increased MVO 2 , nearly all coronary arterial microvesscls dilated ( Figure 4 ). As shown in Figure 4 , dilation of coronary arterial microvessels was heterogeneous. The smaller vessels dilated more than the larger vessels. However, even in the microvessels larger than 150 /tm, there was a significant vasodilation (Figures 4 and 5) . A reduction of hindrance occurred in all observed 301 vessels and was heterogeneous ( Figure 4 ). midmyocardial; Endo, endomyocardial; Trans,
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Diameter Changes in Coronary Arterial Microvessels: Effects of Adenosine Infusion (Group 2)
Adenosine (0.21 ±0.03 mg/kg/min) produced heterogeneous vasodilation, but the vasodilator effect was restricted to arterial microvessels smaller than 150 ixm in diameter ( Figure 6 ). In microvessels larger than 150 tun, there was no significant diameter change ( Figures  5 and 6) . Changes in hindrance were restricted to microvessels smaller than 150 /xm ( Figure 6 ).
Diameter Changes in Coronary Arterial Microvessels: Effects of Dipyridamole Infusion (Group 3)
Dipyridamole (0.23±0.02 mg/kg) produced heterogeneous vasodilation, but the vasodilator effect was restricted to arterial microvessels smaller than 150 ysa in diameter (Figure 7) . In microvessels larger than 150 (.m, there was no significant diameter change ( Figure  5 ). Changes in hindrance were restricted to microvessels smaller than 150 fjum (Figure 7) .
Diameter Changes in Coronary Arterial Microvessels: Effects of Large Doses of Adenosine or Dipyridamole Infusion
Large doses of adenosine (1.1 mg/kg • min) and dipyridamole (1.0 mg/kg) increased the myocardial perfusion fivefold to sevenfold of control value (Figure 2 ), but the vasodilator effects of those agents were restricted to arterial microvessels smaller than 150 /im in diameter even in such high doses (Figures 8 and 9 ).
Discussion
There are three new observations in this study: 1) An increase in MV0 2 produced by rapid pacing caused dilation in all segments of the coronary arterial microvasculatures (40-380 /im). Vasodilation was heterogeneous; that is, greater dilation occurred in smaller arterial microvessels. 2) Exogenous adenosine and endogenous adenosine (dipyridamole) also caused heterogeneous vasodilation, but the dilation produced by endogenous or exogenous adenosine was restricted to arterial microvessels smaller than 150 yum. 3) Comparable degrees of increased myocardial perfusion produced by increas-ing MVO 2 or endogenous or exogenous adenosine did not produce identical segmental dilation of coronary arterial microvessels.
Critique of Methodology
The accuracy of our experimental measurements is critically important to the conclusions of this study. A previous study in our laboratory has shown that the resolution of our imaging system is about 5 fun, which is a small fraction of most of the differences reported in this study. Also, the reproducibility of our measurements is excellent, and diameters measured with polarized light or fiuorescein are nearly identical. 16 In the present study, arterial microvessel diameters were measured only at end diastole. Therefore, we examined the cyclic variation of vessel diameter by comparing measurements of arterial microvessel diameter at midsystole, early diastole, and end diastole. In coronary arterial microvessels, the cyclic variation of vessel diameter was minimal (l.l±0.9% at heart rate^l50 beats/min, 0.1 ±0.6% at heart rate of 270-300 beats/min, n=13). These results are consistent with the report of Ashikawa et a! 19 but not with the report of Tillmanns et al. 20 Both the study by Ashikawa et al 19 ,and our study used methods of measuring microvascular diameters that do not require the microscope objective to have direct contact with the microvessel at any point in the cardiac cycle. Incontrast, Tillmanns et al 20 used an approach to measuring microvascular diameter that requires the microscope objective to In our preparation, many functional parameters (heart rate, arterial pressure, blood gases and pH, control myocardial perfusion, and coronary reserve) were well within the normal physiological range. In addition, the preparation was stable. After cessation of an intervention (rapid pacing or adenosine infusion), changes in microvascular diameters returned to within 5% of the control value in 90% of our experiments; only 10%, which did not meet these criteria, were excluded from results. The restrained and unrestrained segments of the left ventricle were similar with respect to their control perfusion measurements and their responses to dilator stimuli (rapid pacing or adenosine or dipyridamole infusion). The decreased subendocardial/ subepicardial ratio in the restrained left ventricular segments probably was related to decreased MV0 2 secondary to diminished mechanical function in the segments since coronary reserve in the restrained segments was normal. Thus, our experimental findings are not confounded by many measurement errors and unphysiological conditions that could potentially cloud the interpretation of our results.
Heterogeneous Vasodilation Produced by Changes in Metabolism
A few studies have examined responses of different segments of the coronary tree or cerebral circulation to changes in metabolic demand. 2123 In these previous studies, coronary vascular segments were lumped into two classes: proximal conduit coronary vessels and all vessels smaller than the proximal arterial segment. Our study was directed toward assessing segmental responses of a broad range of small resistance vessels to metabolic stimulation. Our results demonstrated heterogeneous responses in the small resistance vessels; that is, greater dilation occurred in smaller arterial microvessels to an increase in MV0 2 .
We can postulate at least three possible mechanisms that would explain the heterogeneous responses: 1) The relative diameter change produced by the smooth-muscle relaxation may be dependent on transmural pressure, which is lower in smaller arterial microvessels. 9 ' 10 ' 11 Cox 24 produced greater diameter change at lower transmural pressure by activating (145 mM K + ) isolated canine left circumflex coronary arteries. Coronary arterial microvessels may respond similarly to metabolic stimulation, but greater vasodilation of smallersized vessels may occur where transmural pressure is lower than that of larger vessels. 2) Only the smaller arterial microvessels may be influenced by metabolic stimulation. Large arterial microvessels may not be exposed to metabolic stimuli but may be principally controlled by changes in vascular shear stress associated with increased coronary blood flow. 25 -27 Thus, relaxation produced by different mechanisms may explain the heterogeneous vasodilation.
3) The mediator(s) of metabolic vasocontrol may produce different responses in differentsized coronary arterial microvessels because of the heterogeneous density or affinity of the receptor in different-sized vessels. It is possible that all of these postulated mechanisms contribute to the heterogeneous dilation that we observed.
Heterogeneous Vasodilation Caused by Exogenous Adenosine and Dipyridamole
In isolated coronary arteries, adenosine has a more potent effect in relaxing smaller coronary vessels. Schnaar and Sparks 12 compared relaxation of large (>1 mm) and small (<0.5 mm) isolated coronary arteries by nitroglycerin and adenosine. These studies showed a more potent relaxing effect of adenosine on isolated small coronary arteries. Also, Harder et al 14 studied effects of adenosine and nitroglycerin on the action potential of large (>1 mm) and small (<0.5 mm) isolated coronary arteries and demonstrated that adenosine blocked the action potential, which was induced by tetraethylammonium ion and electrical stimulation, in the small coronary arteries but not in the large arteries. However, little is known about such a heterogeneous effect of adenosine on coronary vessels smaller than 500 /^m in size. In this study, adenosine produced marked dilation in the coronary arterial microvessels less than 150 ^im but had no effect on vessels larger than 150 /xm. Several studies have examined the dilation of small coronary arterial microvessels to adenosine potentiators. Ashikawa et al 19 have reported significant vasodilation in coronary arterioles less than 50 .m after the intravenous injection of dilazep in the beating dog left ventricle, but they did not examine arterioles larger than 50 /xm. Tillmanns et al 15 have reported the heterogeneous vasodilator effect of dipyridamole on different-sized coronary microvessels of rats and cats; that is, the internal diameter of small arterioles (15-63 /xm) rose by 23%, and those of large arterioles (70-200 fim) did not change after injection of dipyridamole. Although precise comparison of these data with our results is difficult because of different methods and especially animal species, these results strongly suggest that a heterogeneous distribution of adenosine receptors or receptor affinity 28 ' 29 probably accounts for the observed responses to adenosine and dipyridamole.
Even though arterial coronary microvessels greater than 150 /urn in size did not increase in diameter during administration of adenosine or dipyridamole, this does not prove that the smooth muscle in these vascular segments did not decrease in tone. The flow increases produced by adenosine or dipyridamole almost certainly decreased descending pressure in coronary microvessels greater than 150 /xm in diameter. If distending pressure decreased and arterial diameter remained constant, it is plausible to postulate that a modest decrease in smooth muscle tone occurred.
Different Effect of Metabolic Change and Adenosine on Coronary Arterial Microvessels
In this study, adenosine and dipyridamole did not produce the same segmental responses on coronary arterial microvessels as metabolic stimulation. The interpretation of these results must be somewhat guarded, however, because rapid pacing could have direct effects by increasing extravascular compressive force on coronary vessels. Such effects were not present during adenosine or dipyridamole administration. Although this is a possible problem, compressive effects on epicardial vessels are probably minimal. 30 It is easy to explain why intravenous adenosine may cause different effects on the distribution of coronary microvascular resistance than adenosine supposedly released in association with an increase in MVO2. Intraluminal administration of an agent (intravenous adenosine) may have different effects than extraluminal application (endogenous adenosine release). It is far more difficult to explain why pharmacologically induced increases in endogenous adenosine produced by dipyridamole should have dissimilar effects than physiological increases in endogenous adenosine release supposedly produced by metabolic stimulation particularly when the dissimilarity persists over a broad range of dipyridamole doses. Although pharmacologically produced increases in endogenous adenosine could be distributed differently at the microvascular level than physiologically released adenosine, it is at least equally likely that the metabolic coronary dilator response is mediated by stimuli other than or in addition to adenosine. However, it should be acknowledged that our study does not provide definitive evidence against the adenosine hypothesis.
